Detalhe da pesquisa
1.
Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy.
Br J Clin Pharmacol
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340019
2.
Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives.
J Clin Pharmacol
; 62(7): 835-846, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990024
3.
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Eur J Drug Metab Pharmacokinet
; 47(6): 855-868, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178586
4.
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease.
Front Pharmacol
; 13: 814134, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153785
5.
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Clin Pharmacokinet
; 61(3): 375-386, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635995
6.
The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development.
J Clin Pharmacol
; 60 Suppl 1: S77-S97, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205431
7.
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Eur J Drug Metab Pharmacokinet
; 48(1): 119, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517732
8.
Correction to: Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Clin Pharmacokinet
; 61(11): 1641, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112343